Entry |
|
Symbol |
CASP8
|
Name |
(RefSeq) caspase-8 isoform X1
|
KO |
|
Organism |
nle Nomascus leucogenys (northern white-cheeked gibbon)
|
Pathway |
nle04620 | Toll-like receptor signaling pathway |
nle04621 | NOD-like receptor signaling pathway |
nle04622 | RIG-I-like receptor signaling pathway |
nle04625 | C-type lectin receptor signaling pathway |
nle04932 | Non-alcoholic fatty liver disease |
nle05022 | Pathways of neurodegeneration - multiple diseases |
nle05163 | Human cytomegalovirus infection |
nle05167 | Kaposi sarcoma-associated herpesvirus infection |
nle05168 | Herpes simplex virus 1 infection |
nle05170 | Human immunodeficiency virus 1 infection |
|
Brite |
KEGG Orthology (KO) [BR:nle00001]
09130 Environmental Information Processing
09132 Signal transduction
04668 TNF signaling pathway
100586183 (CASP8)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
100586183 (CASP8)
04215 Apoptosis - multiple species
100586183 (CASP8)
04217 Necroptosis
100586183 (CASP8)
04115 p53 signaling pathway
100586183 (CASP8)
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
100586183 (CASP8)
04621 NOD-like receptor signaling pathway
100586183 (CASP8)
04622 RIG-I-like receptor signaling pathway
100586183 (CASP8)
04623 Cytosolic DNA-sensing pathway
100586183 (CASP8)
04625 C-type lectin receptor signaling pathway
100586183 (CASP8)
04657 IL-17 signaling pathway
100586183 (CASP8)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100586183 (CASP8)
05203 Viral carcinogenesis
100586183 (CASP8)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100586183 (CASP8)
05161 Hepatitis B
100586183 (CASP8)
05160 Hepatitis C
100586183 (CASP8)
05164 Influenza A
100586183 (CASP8)
05162 Measles
100586183 (CASP8)
05168 Herpes simplex virus 1 infection
100586183 (CASP8)
05163 Human cytomegalovirus infection
100586183 (CASP8)
05167 Kaposi sarcoma-associated herpesvirus infection
100586183 (CASP8)
05169 Epstein-Barr virus infection
100586183 (CASP8)
05165 Human papillomavirus infection
100586183 (CASP8)
09171 Infectious disease: bacterial
05132 Salmonella infection
100586183 (CASP8)
05134 Legionellosis
100586183 (CASP8)
05152 Tuberculosis
100586183 (CASP8)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
100586183 (CASP8)
05142 Chagas disease
100586183 (CASP8)
09164 Neurodegenerative disease
05010 Alzheimer disease
100586183 (CASP8)
05016 Huntington disease
100586183 (CASP8)
05022 Pathways of neurodegeneration - multiple diseases
100586183 (CASP8)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100586183 (CASP8)
05416 Viral myocarditis
100586183 (CASP8)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
100586183 (CASP8)
04932 Non-alcoholic fatty liver disease
100586183 (CASP8)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
100586183 (CASP8)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:nle01002]
100586183 (CASP8)
Enzymes [BR:nle01000]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.61 caspase-8
100586183 (CASP8)
Peptidases and inhibitors [BR:nle01002]
Cysteine peptidases
Family C14: caspase family
100586183 (CASP8)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
22a:101627600..101678790
|
AA seq |
496 aa
MVPGKGGADYILLPFEKMDFSRNLYDIGEQLGSEDLASLKFLSLDYIPQRKQEPIKDALM
LFQRLQEKRMLEESNLSFLKELLFRINRLDLLIAYLNTRKEEMERELQTPGRAQISAYRV
MLYQISEEVSRSELKSFKFLLQKEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKRV
CAQINKSLLKIINDYEEFSRERRSSLEGNPDEFSNVEELCGVMTISDSPREQDSESQTLD
KVYQMKSKPRGYCLIINNYDFTKAREKVPKLHSIRDRNGTHLDAGALTTTFEELHFEIKP
HNDCTVQQIYEILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGKEAPIYELTSQFTGL
KCPSLAGKPKVFFIQACQGDNYQKGIPVETDSEEQPYLEMDLSSPQARYIPDEADFLLGM
ATVNNCVSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNYEVSNKDDKKNMGKQM
PQPTFTLRKKLVFPSD |
NT seq |
1491 nt +upstreamnt +downstreamnt
atggtgccaggaaagggtggagcggattatattctcctgccttttgaaaagatggacttc
agtagaaatctttatgatattggggaacaactgggcagtgaagatctggcctccctcaag
ttcctgagcctggactacattccacaaaggaagcaagaacccatcaaggatgccttgatg
ttattccagagactccaggaaaagagaatgttggaggaaagcaatctgtccttcctgaag
gagctgctcttccgaattaatagactggatttgctgattgcctacctaaacactagaaag
gaggagatggaaagggaacttcagacaccaggcagggctcagatttctgcctacagggtc
atgctgtatcagatttcagaagaagtgagcagatcagaattgaagtcttttaagtttctt
ttgcaaaaggaaatctccaaatgcaaactggatgatgacatgaacctgctggatattttc
atagagatggagaagagggtcatcctgggagaaggaaagttggacatcctgaaaagagtc
tgtgcccaaatcaacaagagcctgctgaagataattaacgactatgaagaattcagcaga
gagagaagaagcagccttgaaggaaatcctgatgaattttcaaatgtggaggagttgtgt
ggggtaatgacaatctcggactctccaagagaacaggatagtgaatcacagactttggac
aaagtttaccaaatgaaaagcaaacctcgaggatactgtctgatcatcaacaattacgat
tttacaaaagcacgggagaaagtgcccaaacttcacagcattagggacaggaatggaaca
cacttggatgcaggggctttgaccacgacctttgaagagcttcattttgagatcaagccc
cacaatgactgcacagtacagcaaatctatgagattttgaaaatctaccaactcatggac
cacagtaacatggactgcttcatctgctgtatcctctcccatggagacaagggcatcatc
tacggcactgatggcaaggaggcccccatctatgagctgacatctcagttcactggtttg
aagtgcccttcccttgctggaaaacccaaagtgttttttattcaggcttgtcagggggat
aactaccagaaaggtatacctgttgagactgattcagaggagcaaccctatttagaaatg
gatttatcatcacctcaggcgagatatatcccggatgaggctgactttctgctggggatg
gccactgtgaataactgtgtttcctaccgaaatcctgcagagggaacctggtacatccag
tcactttgccagagcctgagggagcgatgtcctcgaggcgatgatattctcaccatcctg
actgaagtgaactatgaagtaagcaacaaggatgacaagaaaaacatggggaaacagatg
ccgcagcctactttcacactaagaaaaaaacttgtcttcccttctgattga |